Makris, Nikolaos
Rathi, Yogesh
Mouradian, Palig
Bonmassar, Giorgio
Papadimitriou, George
Ing, Wingkwai I.
Yeterian, Edward H.
Kubicki, Marek
Eskandar, Emad N.
Wald, Lawrence L.
Fan, Qiuyun
Nummenmaa, Aapo
Widge, Alik S.
Dougherty, Darin D.
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (R21EB016449)
National Institutes of Health (5 UO1 MH 093765-05)
National Institute of Mental Health (RO1MH097979)
National Institute of Mental Health (R01 MH102377)
Colby College Research Fund (01 2836)
Article History
First Online: 30 October 2015
Compliance with ethical standards
:
: This study was supported, in part, by grants from: NIH, NIBIB R21EB016449 (NM and GB); from NIH, 5 UO1 MH 093765-05 (LW, QF and AN); from NIMH, RO1MH097979 (YR); from NIMH, R01 MH102377 (MK and NM); from Colby College Research Fund 01 2836 (EY); from Medtronic, Cyberonics, Roche and Eli Lilly and Company (DD).
: Nikolaos Makris, Yogesh Rathi, Palig Mouradian, Giorgio Bonmassar, George Papadimitriou, Wingkwai I. Ing, Edward H. Yeterian, Marek Kubicki, Lawrence Wald, Qiuyun Fan, Aapo Nummenmaa declare that they have no conflict of interest. Darin D. Dougherty has receivedspeaker honoraria from Insys and Johnson & Johnson, and has received research grants from Medtronic, Cyberonics, Roche and Eli Lilly. Alik S. Widge, Darin Dougherty and Emad N. Eskandar are named inventors on patents related to improved targeting and delivery of deep brain stimulation.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, and the applicable revisions at the time of the investigation. Informed consent was obtained from all patients included in the study.